ANBT
BNTX icon

American National Bank & Trust’s BioNTech BNTX Stock Holding History

American National Bank & Trust’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-880
Closed -$93.7K – 643
2025
Q2 		$93.7K Hold
880
– – 0.01% 318
2025
Q1 		$80.1K Hold
880
– – 0.01% 292
2024
Q4 		$100K Hold
880
– – 0.01% 258
2024
Q3 		$105K Hold
880
– – 0.01% 253
2024
Q2 		$70.7K Hold
880
– – 0.01% 296
2024
Q1 		$81.2K Buy
+880
New +$84.4K 0.01% 266

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

American National Bank & Trust's BNTX Position: Q3 2025 in Review

American National Bank & Trust sold out of BioNTech (BNTX) in Q3 2025, closing a stake of 880 shares — an estimated $93.7K sold.

American National Bank & Trust first reported a position in BNTX in Q1 2024 and held it in 6 quarters. The position peaked at $105K in Q3 2024. 254 funds tracked by Wall St. Rank hold BNTX as of Q3 2025.

  • American National Bank & Trust reported no remaining BioNTech position as of Q3 2025 after selling out during the quarter.
  • American National Bank & Trust sold 880 BioNTech shares in Q3 2025, an estimated $93.7K.
  • American National Bank & Trust first reported a position in BioNTech in Q1 2024 and held it in 6 quarters.
  • American National Bank & Trust's BioNTech position peaked at $105K in Q3 2024.
  • 254 funds tracked by Wall St. Rank held BioNTech as of Q3 2025.

Based on American National Bank & Trust's 13F filing for Q3 2025, filed 21 Oct 2025.